Effect of diazoxide on glucose U-C-14 utilization in mice.
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002247:Carbon Isotopes; D003981:Diazoxide / Q000008:administration & dosage*; D004822:Epididymis / Q000378:metabolism; D005227:Fatty Acids / Q000096:biosynthesis*; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000096:biosynthesis*; D006943:Hyperglycemia / Q000139:chemically induced; D007279:Injections, Subcutaneous; D007328:Insulin / Q000494:pharmacology / Q000502:physiology; D008099:Liver / Q000378:metabolism*; D008112:Liver Glycogen / Q000096:biosynthesis; D008297:Male; D051379:Mice
D001786:Blood Glucose; D002247:Carbon Isotopes; D005227:Fatty Acids; D007328:Insulin; D008112:Liver Glycogen; D006003:Glycogen; D005947:Glucose; D003981:Diazoxide